Results 241 to 250 of about 185,125 (388)

Medications, epilepsy and climate change: Added layers of complexity

British Journal of Clinical Pharmacology, EarlyView.
Climate change—the global crisis with pervasive health impacts—has adverse consequences for people with epilepsy (PWE) who have low quality of life due to poor seizure control, socioeconomic disadvantages and comorbidities. This review focuses on the potential effects of climate change on the pharmacological characteristics of antiseizure medications ...
Medine I. Gulcebi, Seyhmus Gavas, Sanjay M. Sisodiya   +2 more
wiley   +1 more source

Eosinophilic Esophagitis on and off Proton Pump Inhibitor

GE: Portuguese Journal of Gastroenterology, 2023
Vincent Zimmer, Kai Emrich
doaj   +1 more source

Uptake sites of H2 blocker and proton pump inhibitor reveal the heterogeneity of parietal and interstitial cells

, 2000
Masahiko Nakamura, Kanji Tsuchimoto, Masaya Oda, Hiromasa Ishii, Eric R. Lacy   +4 more
openalex   +1 more source

Problems Associated with the Clinical Use of Proton Pump Inhibitors [PDF]

, 2001
Derek Gillen, Kenneth E.L. McColl
openalex   +1 more source

Proton Pump Inhibitor Omeprazole Alters the Spiking Characteristics of Proteinoids. [PDF]

ACS Omega
Mougkogiannis P, Adamatzky A.
europepmc   +1 more source

Pharmacogenomics in the UK National Health Service: Progress towards implementation

British Journal of Clinical Pharmacology, EarlyView.
Over the past decade there has been considerable and growing enthusiasm about the promise of using genomics to inform healthcare. In particular, using genetic data to inform prescribing practice has emerged as a compelling policy priority for health systems around the world, not least in the NHS.
John H. McDermott, Maria Tsakiroglou, William G. Newman, Munir Pirmohamed   +3 more
wiley   +1 more source

Factors affecting Helicobacter pylori eradication using a seven-day triple therapy with a proton pump inhibitor, tinidazole and clarithromycin, in brazilian patients with peptic ulcer [PDF]

, 2001
Fernando Marcuz Silva, Schlioma Zaterka, Jaime Natan Eisig, Ethel Zimberg Chehter, Décio Chinzon, Antônio Atílio Laudanna   +5 more
openalex   +1 more source

Knowledge, Attitudes, and Practices of Community Pharmacists Regarding Proton Pump Inhibitor (PPI) Use: A Cross-Sectional Study. [PDF]

Healthcare (Basel)
Moustafa HAM, Al Meslamani AZ, Ahmed HMME, Ahmed SAF, Sallam NES, Alshehri GH, Alsubaie N, Kassem AB.   +7 more
europepmc   +1 more source

Artificial intelligence modelling of tyrosine kinase inhibitors at risk of malabsorption and bioavailability‐enhancing strategies

British Journal of Clinical Pharmacology, EarlyView.
Aims The study aims to predict and improve the absorption of tyrosine kinase inhibitors (TKIs) in patients with malabsorption issues, particularly those who have undergone bariatric surgery or are using proton‐pump inhibitors. The research involves 2 main components: the development of an artificial intelligence (AI) model to identify TKIs that are ...
Daan W. Huntjens, Olivier J. M. Béquignon, Stefanie D. Krens, Mark Löwenberg, Martine E. D. Chamuleau, Remco J. Molenaar, Anita M. G. Kramers, Marianne A. Kuijvenhoven, Imke H. Bartelink   +8 more
wiley   +1 more source

Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.

The Medical clinics of North America, 2019
R. Yadlapati, Kelli DeLay
semanticscholar   +1 more source